• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球癌症控制:应对日益加重的负担、不断上升的成本以及获取资源方面的不平等现象。

Global cancer control: responding to the growing burden, rising costs and inequalities in access.

作者信息

Prager Gerald W, Braga Sofia, Bystricky Branislav, Qvortrup Camilla, Criscitiello Carmen, Esin Ece, Sonke Gabe S, Martínez Guillem Argilés, Frenel Jean-Sebastian, Karamouzis Michalis, Strijbos Michiel, Yazici Ozan, Bossi Paolo, Banerjee Susana, Troiani Teresa, Eniu Alexandru, Ciardiello Fortunato, Tabernero Josep, Zielinski Christoph C, Casali Paolo G, Cardoso Fatima, Douillard Jean-Yves, Jezdic Svetlana, McGregor Keith, Bricalli Gracemarie, Vyas Malvika, Ilbawi André

机构信息

Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.

Instituto CUF Oncologia, NOVA Medical School, Lisboa, Portugal.

出版信息

ESMO Open. 2018 Feb 2;3(2):e000285. doi: 10.1136/esmoopen-2017-000285. eCollection 2018.

DOI:10.1136/esmoopen-2017-000285
PMID:29464109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5812392/
Abstract

The cancer burden is rising globally, exerting significant strain on populations and health systems at all income levels. In May 2017, world governments made a commitment to further invest in cancer control as a public health priority, passing the World Health Assembly Resolution 70.12 on cancer prevention and control within an integrated approach. In this manuscript, the 2016 European Society for Medical Oncology Leadership Generation Programme participants propose a strategic framework that is in line with the 2017 WHO Cancer Resolution and consistent with the principle of universal health coverage, which ensures access to optimal cancer care for all people because health is a basic human right. The time for action is now to reduce barriers and provide the highest possible quality cancer care to everyone regardless of circumstance, precondition or geographic location. The national actions and the policy recommendations in this paper set forth the vision of its authors for the future of global cancer control at the national level, where the WHO Cancer Resolution must be implemented if we are to reduce the cancer burden, avoid unnecessary suffering and save as many lives as possible.

摘要

全球癌症负担正在上升,给所有收入水平的人群和卫生系统带来了巨大压力。2017年5月,世界各国政府承诺进一步投资癌症控制,将其作为公共卫生优先事项,通过了世界卫生大会关于在综合方法中预防和控制癌症的第70.12号决议。在本手稿中,2016年欧洲医学肿瘤学会领导力培养计划的参与者提出了一个战略框架,该框架符合2017年世界卫生组织癌症决议,并与全民健康覆盖原则相一致,全民健康覆盖确保所有人都能获得最佳癌症护理,因为健康是一项基本人权。现在是采取行动的时候了,要减少障碍,为每个人提供尽可能高质量的癌症护理,无论其情况、前提条件或地理位置如何。本文中的国家行动和政策建议阐述了作者对国家层面全球癌症控制未来的愿景,如果我们要减轻癌症负担、避免不必要的痛苦并尽可能挽救更多生命,就必须在国家层面实施世界卫生组织癌症决议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/5812392/40e5b5e9e4e2/esmoopen-2017-000285f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/5812392/5fcdbd93724c/esmoopen-2017-000285f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/5812392/bc2f7864ee53/esmoopen-2017-000285f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/5812392/40e5b5e9e4e2/esmoopen-2017-000285f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/5812392/5fcdbd93724c/esmoopen-2017-000285f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/5812392/bc2f7864ee53/esmoopen-2017-000285f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d60d/5812392/40e5b5e9e4e2/esmoopen-2017-000285f03.jpg

相似文献

1
Global cancer control: responding to the growing burden, rising costs and inequalities in access.全球癌症控制:应对日益加重的负担、不断上升的成本以及获取资源方面的不平等现象。
ESMO Open. 2018 Feb 2;3(2):e000285. doi: 10.1136/esmoopen-2017-000285. eCollection 2018.
2
Tuberculosis结核病
3
Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countries低收入和中等收入国家家庭慢性疾病和伤害的经济负担
4
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
5
Universal Health Coverage and Essential Packages of Care全民健康覆盖与基本医疗服务包
6
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.《2023年健康与气候变化倒计时拉丁美洲报告:以健康为中心的气候适应型发展的必要性》
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.基于 204 个国家和地区 1990 年至 2019 年卫生服务有效覆盖指数测量全民健康覆盖:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1250-1284. doi: 10.1016/S0140-6736(20)30750-9. Epub 2020 Aug 27.
9
Can hepatitis C be eradicated in the United States?在美国丙型肝炎能被根除吗?
Antiviral Res. 2014 Oct;110:79-93. doi: 10.1016/j.antiviral.2014.07.015. Epub 2014 Aug 7.
10
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.

引用本文的文献

1
Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping.拉丁美洲癌症精准医学与健康公平:增进对政策制定和卫生系统塑造的理解
Int J Environ Res Public Health. 2025 Aug 5;22(8):1220. doi: 10.3390/ijerph22081220.
2
Spatial and spatio-temporal analysis of cancer mortality in Iran: gender disparities and implications for health policy.伊朗癌症死亡率的空间和时空分析:性别差异及其对卫生政策的影响。
Prev Med Rep. 2025 Aug 5;57:103180. doi: 10.1016/j.pmedr.2025.103180. eCollection 2025 Sep.
3
Exploring microRNA targeting as a promising approach for solid tumor treatment.

本文引用的文献

1
ESMO Leaders Generation Programme: an alumni insight.欧洲肿瘤内科学会(ESMO)领导者培养计划:校友见解
ESMO Open. 2018 Jan 29;3(1):e000312. doi: 10.1136/esmoopen-2017-000312. eCollection 2018.
2
ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe.欧洲肿瘤内科学会国际联盟关于欧洲以外国家抗肿瘤药物的可及性、自付费用和可获得性的研究
Ann Oncol. 2017 Nov 1;28(11):2633-2647. doi: 10.1093/annonc/mdx521.
3
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.
探索将微小RNA靶向作为实体瘤治疗的一种有前景的方法。
Front Oncol. 2025 Jul 21;15:1570093. doi: 10.3389/fonc.2025.1570093. eCollection 2025.
4
Natural Phytochemicals from Brenan: A Cytotoxic and Computational Analysis against Cancer Targets.来自布伦南的天然植物化学物质:针对癌症靶点的细胞毒性和计算分析
ACS Omega. 2025 Jul 14;10(29):32097-32111. doi: 10.1021/acsomega.5c02969. eCollection 2025 Jul 29.
5
Revisiting Alma Ata: A Blueprint for Cancer Care.重温阿拉木图宣言:癌症护理蓝图
Cancer Control. 2025 Jan-Dec;32:10732748251363701. doi: 10.1177/10732748251363701. Epub 2025 Jul 30.
6
Optimizing Oncology Generic Medication Selection in the Gulf Region: Expert Consensus and MCDA Tool Development.优化海湾地区肿瘤学仿制药的选择:专家共识与多标准决策分析工具开发
J Health Econ Outcomes Res. 2025 Jul 18;12(2):21-26. doi: 10.36469/001c.140955. eCollection 2025.
7
HPV cancer burden by anatomical site, country, and region in 2022.2022年按解剖部位、国家和地区划分的人乳头瘤病毒相关癌症负担
Sci Rep. 2025 Jul 1;15(1):21048. doi: 10.1038/s41598-025-06700-8.
8
Acquired resistance to molecularly targeted therapies for cancer.癌症对分子靶向治疗的获得性耐药。
Cancer Drug Resist. 2025 Jun 5;8:27. doi: 10.20517/cdr.2024.189. eCollection 2025.
9
Using cancer survivorship experiences to inform cancer advocacy in Nigeria.利用癌症幸存者经历为尼日利亚的癌症宣传提供信息。
Ecancermedicalscience. 2025 Apr 10;19:1887. doi: 10.3332/ecancer.2025.1887. eCollection 2025.
10
Collaborative frontiers in pediatric neuro-oncology: establishing an international tumor board for enhanced care and global impact.儿科神经肿瘤学的合作前沿:建立一个国际肿瘤学委员会以加强护理并产生全球影响。
Int J Clin Oncol. 2025 May 30. doi: 10.1007/s10147-025-02793-3.
欧洲肿瘤内科学会/美国临床肿瘤学会2016年版《全球医学肿瘤学课程推荐》
ESMO Open. 2016 Sep 29;1(5):e000097. doi: 10.1136/esmoopen-2016-000097. eCollection 2016.
4
ESMO and WHO: 14 years of working in partnership on cancer control.欧洲肿瘤内科学会(ESMO)与世界卫生组织(WHO):在癌症控制领域合作的14年。
ESMO Open. 2016 May 26;1(3):e000012. doi: 10.1136/esmoopen-2015-000012. eCollection 2016.
5
Back to the 'essence' of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines.回归肿瘤医学治疗的“本质”:《2015年世界卫生组织基本药物示范清单》
ESMO Open. 2016 Mar 21;1(2):e000030. doi: 10.1136/esmoopen-2015-000030. eCollection 2016.
6
Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study.估算乳腺癌化疗特定方案的成本:观察性队列研究。
Cancer. 2016 Nov 15;122(22):3447-3455. doi: 10.1002/cncr.30274. Epub 2016 Oct 10.
7
Differences in availability of cancer drugs across Europe.欧洲各地癌症药物可及性的差异。
Lancet Oncol. 2016 Sep;17(9):1196. doi: 10.1016/S1470-2045(16)30378-3. Epub 2016 Jul 29.
8
Global burden of cancers attributable to infections in 2012: a synthetic analysis.2012 年归因于感染的癌症全球负担:综合分析。
Lancet Glob Health. 2016 Sep;4(9):e609-16. doi: 10.1016/S2214-109X(16)30143-7. Epub 2016 Jul 25.
9
ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe.ESMO 欧洲联合体研究:在欧洲,抗肿瘤药物的可获得性、自付费用和可及性。
Ann Oncol. 2016 Aug;27(8):1423-43. doi: 10.1093/annonc/mdw213.
10
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition.在低收入和中等收入国家实施癌症控制基本干预措施组合的成本、可负担性和可行性:《疾病控制优先事项》第三版的主要内容。
Lancet. 2016 May 21;387(10033):2133-2144. doi: 10.1016/S0140-6736(15)00755-2. Epub 2015 Nov 11.